Open access · OA
via OpenAlex
Changes of the Functional Capacity of Mesenchymal Stem Cells due to Aging or Age-Associated Disease – Implications for Clinical Applications and Donor Recruitment
Günter Lepperdinger, Regina Brunauer, Robert J. Gassner, Angelika Jamnig, Frank Rudolf Kloss, Gerhard Thomas Laschober
Transfusion Medicine and Hemotherapy · 2008 · ▲ 15 citations
Abstract
SUMMARY: In contrast to stem cells of embryonic origin, autologous tissue-specific stem cells are easier to introduce into the clinical practice. In this context, molecular and cellular changes, which alter tissue-specific stem cell properties with age, are of particular interest since elderly patients represent the main target group for cell-based therapies. The clinical use of mesenchymal stem cells is an emerging field, especially because this stem cell type appears to be amenable for the treatment of a large number of diseases, such as non-healing bone defects and fractures, inflammatory relief during arthritis, and the repair of suspensory ligament tears. More than that, mesenchymal stem cells provoke effective immune suppression in the context of graft-versus-host disease. Here, we present a comprehensive overview of the recent findings with special attention to age-related changes of mesenchymal stem cell properties and the consequential impact on tissue regeneration and repair, together with the current perception concerning their therapeutic application potential as well as the challenges associated with their clinical use.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1159/000142373
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Lepperdinger, G., Brunauer, R., Gassner, R.J., Jamnig, A., Kloss, F.R., & Laschober, G.T. (2008). Changes of the Functional Capacity of Mesenchymal Stem Cells due to Aging or Age-Associated Disease – Implications for Clinical Applications and Donor Recruitment. <em>Transfusion Medicine and Hemotherapy</em>. https://doi.org/10.1159/000142373
Vancouver
Lepperdinger G, Brunauer R, Gassner RJ, Jamnig A, Kloss FR, Laschober GT. Changes of the Functional Capacity of Mesenchymal Stem Cells due to Aging or Age-Associated Disease – Implications for Clinical Applications and Donor Recruitment. Transfusion Medicine and Hemotherapy. 2008. doi:10.1159/000142373.
BibTeX
@article{gnter2008Change,
title = {Changes of the Functional Capacity of Mesenchymal Stem Cells due to Aging or Age-Associated Disease – Implications for Clinical Applications and Donor Recruitment},
author = {Günter Lepperdinger and Regina Brunauer and Robert J. Gassner and Angelika Jamnig and Frank Rudolf Kloss and Gerhard Thomas Laschober},
journal = {Transfusion Medicine and Hemotherapy},
year = {2008},
doi = {10.1159/000142373},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Veterinary Science 2017
Open access · CC-BY
Effect of donor age on the proliferation and multipotency of canine adipose-derived mesenchymal stem cells
Cells 2021
Open access · CC-BY
Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials
Stem Cell Investigation 2019
Open access · CC-BY
Telomere shortening as a hallmark of stem cell senescence
Mechanisms of Ageing and Development 2012
Citation only
Age-related alterations in mesenchymal stem cells related to shift in differentiation from osteogenic to adipogenic potential: Implication to age-associated bone diseases and defects
Stem Cells 2015
Open access · CC-BY
Abrogation of Age-Induced MicroRNA-195 Rejuvenates the Senescent Mesenchymal Stem Cells by Reactivating Telomerase
Nature Reviews Rheumatology 2013
Preprint · OA